GSK & Sanofi strike deal to supply UK with up to 60m doses of...
Sanofi and GSK have reached an agreement* with the UK government for the supply of up to 60 million doses of a COVID-19 vaccine. Developed...
High-risk groups should have priority for COVID-19 vaccine – poll
The biopharmaceutical industry believes that high-risk groups should be prioritised for the COVID-19 vaccine, according to a poll by GlobalData. Nearly half of global respondents...
AMBAR clinical trial results published in Journal of the Alzheimer’s Association
Peer-reviewed scientific journal, Alzheimer’s & Dementia: The Journal of the Alzheimer's Association, has published the results of Grifols’ AMBAR clinical trial. This study was...
AstraZeneca’s Imfinzi recommended for approval in the EU
AstraZeneca’s Imfinzi (durvalumab) has been recommended for marketing authorisation in the European Union (EU) for the 1st-line treatment of adults with extensive-stage small cell...
Novartis launches first-of-its-kind not-for-profit portfolio of medicines for symptomatic treatment of COVID-19
Novartis has launched a first-of-its-kind not-for-profit portfolio of medicines for the symptomatic treatment of COVID-19. Novartis has announced a new initiative to help patients in...
Oxford coronavirus vaccine produces strong immune response
A new study has revealed that the Oxford coronavirus vaccine produces a strong immune response. The results of the Phase I/II trial published in the...
UK secures early access to promising COVID-19 vaccine candidates
Millions of people could be vaccinated against coronavirus as the UK secures early access to 90 million doses of promising COVID-19 vaccine candidates. Announced by...
MHRA grants early access to lumasiran
Alnylam has announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has granted early access to lumasiran. Alnylam Pharmaceuticals, Inc, the leading RNAi therapeutics...
Medicago begins Phase I clinical trials for its COVID-19 vaccine candidate
Medicago, a biopharmaceutical company headquartered in Quebec City, has started Phase I clinical trials for its plant-derived COVID-19 vaccine candidate, administering the first doses...
NICE recommends ADCETRIS▼ (brentuximab vedotin), in combination with chemotherapy, as frontline treatment for a...
Takeda UK has announced that the National Institute for Health and Care Excellence (NICE) has recommended ADCETRIS (brentuximab vedotin) with cyclophosphamide, doxorubicin and prednisone...
Latest articles
Atrial Fibrillation Toolkit: Tackling avoidable strokes to save lives and strain on the NHS
The AHSN Network of 15 Academic Health Science Networks in England has launched the national ‘Atrial Fibrillation Toolkit’ (www.aftoolkit.co.uk) to address barriers to stroke...
Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Primary care networks and mental health services post COVID-19
Joint working between primary care networks and providers of mental health services must accelerate if the NHS is to help the huge increase in...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Data in NEJM demonstrates efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis announces publication of Phase III ASCLEPIOS trials data in NEJM demonstrating efficacy of the ofatumumab in patients with relapsing multiple sclerosis. Novartis has announced...
Accelerated use of electronic prescribing
Deborah Evans, Managing Director of Pharmacy Complete, looks at the instruction to stay at home, GP surgeries closing their doors and consumers rethinking how...
COVID-19: Pharma on the frontline
Pharma stepped up to support the NHS, the country and the World during the COVID-19 pandemic. Pf brings you some examples of pharma on...
ABPI Code and promotional emails
Dr Rina Newton, Managing Director of CompliMed, looks at the considerations relating to the ABPI Code of Practice and promotional emails. In the June issue...